Invention Application
- Patent Title: COMPOSITION FOR PREVENTING OR TREATING DIABETES MELLITUS
-
Application No.: US17820387Application Date: 2022-08-17
-
Publication No.: US20220387450A1Publication Date: 2022-12-08
- Inventor: Kyong Soo PARK , Seung-Ah LEE , Sung Soo CHUNG
- Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION , Seoul National University Hospital
- Applicant Address: KR Seoul; KR Seoul
- Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION,Seoul National University Hospital
- Current Assignee: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION,Seoul National University Hospital
- Current Assignee Address: KR Seoul; KR Seoul
- Priority: KR10-2020-0019298 20200217,KR10-2020-0116891 20200911
- Main IPC: A61K31/575
- IPC: A61K31/575 ; A61P3/10 ; A61K31/609 ; A61K31/58 ; A61K38/19 ; A61K31/395 ; A61K31/132 ; A61K31/7008 ; A61K31/455

Abstract:
The present invention relates to a composition for preventing or treating diabetes mellitus using a 4-component mixture of putrescine, glucosamine, nicotinamide, and a STAT3 inhibitor. It has been confirmed that blood glucose is stably regulated when a compound of the 4-component mixture according to the present invention is injected into the caudal vein of a diabetes mellitus-induced mouse. The compound can be practically and usefully used as a therapeutic agent for diabetes mellitus patients and patients exposed to diabetes mellitus risk.
Information query